ArticleInternal medicine (Tokyo, Japan)2026

Effective Treatment with Ruxolitinib and Ropeginterferon Alfa-2b for Refractory TAFRO-like Syndrome.

Satoko Oka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.